Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMCN.L Regulatory News (NMCN)

  • There is currently no data for NMCN

Further Covid-19 Update

14 Apr 2020 10:00

RNS Number : 5438J
NMCN PLC
14 April 2020
 

14 April 2020

 

nmcn PLC

 

("nmcn" or the "Company" or the "Group")

 

Further Covid-19 Update

 

As previously stated, nmcn will be reporting its 2019 Preliminary Results on Thursday 23 April. However, in light of the extraordinary circumstances emerging from the Covid-19 virus we want to update stakeholders further on how we are responding. nmcn is endeavouring to take all appropriate steps to protect the health and wellbeing of its staff, customers and suppliers and to fully comply with Government requirements and requests.

 

Furthermore, we continue to seek to be a responsible member of the communities in which we operate and serve, whilst positioning our business to emerge from this unprecedented period in the strongest possible condition.

 

Operational implications

 

The potential impact of Covid-19 on the Group's trading performance for the balance of 2020 remains unclear. We are experiencing disruption in certain areas, but where safe to do so, nmcn continues to be operational across many of its sectors. In Water, which accounts for circa two thirds of our overall revenues, we are working closely with our customers, across multiple business workstreams, that are designated by the Government to be critical to the Covid-19 response. There is a clear commitment and ongoing demand for our directly delivered services.

 

Built Environment, Telecommunications and Highways have also been designated 'critical sectors' and we remain operational to some degree here too, with the workforce engaged in all areas where we have framework and ongoing contractual requirements. Our services in Building have been disrupted with a temporary cessation of works at the majority of our sites. 

Where it is safe to do so, we continue to work on those projects that are deemed to be in areas of critical national significance to the Covid-19 response. Presently such activities represent up to 70% of the workload we would anticipate in a more normal operating environment.

 

Financial implications

Since the escalation of the Covid-19 pandemic, the Board has been focussed on taking actions to preserve cash and protect liquidity in a way that does not compromise the long-term prospects of the business. To this end we have implemented a temporary and voluntary reduction in the remuneration of the Board of 20% and a 10% reduction for the senior management team (effective 1 April 2020). All non-essential capital and overhead expenditure has now been deferred, and a hiring freeze has been implemented along with various other cost reduction initiatives. Measures taken to reduce cash outflows include the deferral of VAT payment, financing costs, and utilisation of the Government's Job Retention Scheme.

As part of a review of capital allocation across the business, and recognising the uncertainties posed by the Covid-19 crisis, in particular the possibility of further restrictions or extended time frames, the Board will not be recommending a final dividend for 2019. The Board is very mindful of the importance of dividends to all shareholders and should circumstances permit a special interim dividend may be made later this year. The 2019 Directors' bonus payments are currently being deferred along with the vesting of the 2017 LTIPs. No new LTIPs will be awarded until the current uncertainties have diminished.

As a result of our prudent approach to the balance sheet we entered 2020 with a net cash position in excess of £25.8 million (unaudited), but in order to provide headroom and flexibility in the current circumstances, additional borrowing facilities are being considered by the Board. Working capital, in particular, will be important to address the opportunities that a recovering market may present. Discussions are also progressing with Lloyds Bank to utilise the recently announced Coronavirus Large Business Interruption Loan Scheme (CLBILS).

We believe these actions to be prudent in light of the uncertain macro outlook, and notwithstanding the essential nature of much of the work we undertake and the covenant strength of our customers. With the commitment of a highly skilled and dedicated workforce, we are adjusting to the evolving challenges of a global event. The Board is confident of the Company's ability to survive the storm and to emerge as a strong contender in its chosen markets, yet we are not able to quantify the likely impact on the 2020 full year results at this stage and consequently the Board does not believe it appropriate to provide forward looking financial guidance until greater visibility is available.

A further update on current trading will be provided with the Preliminary Results on Thursday 23rd April.

Chief Executive Officer, John Homer, commented:

"I would like to thank all my colleagues within nmcn and our external stakeholders for their flexibility and resolve in addressing such extraordinary circumstances. We seek to produce a holistic response to the challenges of Covid-19 which balances self-help with Government initiatives in a commercially robust but fair manner."

For further information please contact:

 

nmcn PLC - 01623 515 008

John Homer, Chief Executive

Dan Taylor, Chief Financial Officer

About nmcn

 

nmcn Plc is a leading engineering and construction company in the UK. Its talented 1800-strong team offers multi-sector engineering and construction skills, technical innovation, design and specialist fabrication.

 

The Company delivers major built environment and water industry projects across the UK - from buildings and highways to large-scale water networks and treatment plants. With its history dating back to 1946, nmcn now has 12 UK offices and four off-site manufacturing facilities.

 

www.nmcn.com

 

This disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUSSWRRNUSARR
Date   Source Headline
6th Oct 20215:49 pmRNSAppointment of Administrators
4th Oct 20215:30 pmRNSNMCN
4th Oct 202112:26 pmRNSNotice of intention to appoint administrators
1st Oct 20214:19 pmRNSUpdate on publication of the Group's annual report
24th Sep 202110:07 amRNSUpdate on results, refinancing and proposed move
25th Aug 20212:50 pmRNSUpdate on 2020 Results, Prospectus and Circular
2nd Aug 20212:51 pmRNSUpdate on 2020 results
20th Jul 20212:06 pmRNSUpdate on 2020 Result, Financing and Result of GM
15th Jul 20218:21 amRNSGeneral Meeting Details
29th Jun 20218:00 amRNSUpdate on 2020 results, temporary suspension
29th Jun 20217:30 amRNSSuspension - NMCN PLC
24th Jun 20217:00 amRNSPosting of Circular and notice of General Meeting
22nd Jun 20219:05 amRNSSecond Price Monitoring Extn
22nd Jun 20219:00 amRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSFinancing Update
14th Jun 20217:00 amRNSFinancing and Trading Update
7th Jun 20217:00 amRNSHolding(s) in Company
28th May 20212:06 pmRNSSecond Price Monitoring Extn
28th May 20212:00 pmRNSPrice Monitoring Extension
28th May 202111:05 amRNSSecond Price Monitoring Extn
28th May 202111:00 amRNSPrice Monitoring Extension
28th May 20217:00 amRNSFinancing and Trading Update
17th May 20217:00 amRNSAppointment of new Chief Executive Officer
16th Apr 20213:21 pmRNS£8.9m facility concluded & Notice of results
12th Apr 20217:00 amRNSAppointment of new Chief Executive Officer
6th Apr 20217:00 amRNSFinancing Update
31st Mar 20217:01 amRNSFinancing Update
4th Mar 202112:19 pmRNSDirectorate Change
26th Feb 20219:54 amRNSResult of General Meeting
23rd Feb 20211:23 pmRNSTrading Update and Notice of Results
3rd Feb 20217:00 amRNSPosting of Circular and Notice of General Meeting
28th Jan 20217:00 amRNSAppointment of CEO
23rd Dec 202012:00 pmRNSAppointment of Financial Adviser and Broker
23rd Dec 20207:00 amRNSTrading & Board Change Update
28th Oct 20208:23 amRNSAppointment of new Chief Financial Officer
15th Oct 20207:00 amRNSTrading Update
29th Sep 20203:11 pmRNSExternal Auditor Appointment
24th Sep 20204:30 pmRNSBoard Changes and Trading Update
9th Sep 202011:00 amRNSAppointment of Company Secretary
28th Aug 202012:12 pmRNSBoard Changes - Update
7th Aug 20207:04 amRNSProgressive publishes new research
6th Aug 20207:00 amRNSHalf Year Report
24th Jul 202010:00 amRNSBoard Change
25th Jun 20204:19 pmRNSResult of Annual General Meeting
25th Jun 20207:00 amRNSAGM Trading Update
27th May 20207:00 amRNS2019 Report & Accounts & 2020 AGM Notice posted
21st May 20207:00 amRNSDisclosure of rights attached to Equity Shares
4th May 202011:16 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNS2019 Final Results & Further COVID-19 Update
14th Apr 202010:00 amRNSFurther Covid-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.